Evaluation of persistence of terbinafine in the hair of normal cats after 14 days of daily therapy

Veterinary Dermatology

Volumn 18, Issue 4, 2007, Pages 246-251

  Foust, Abby L ^a,c   Marsella, Rosanna ^a   Akucewich, Lisa H ^a   Kunkle, Gail ^a   Stern, Amy ^a   Moattari, Syamak ^b   Szabo, Nancy J ^b  

^a University of Florida   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; NAPHTHALENE DERIVATIVE; TERBINAFINE;

ANIMAL; ARTICLE; CAT; DRUG ADMINISTRATION; EVALUATION; FEMALE; HAIR; MALE; METABOLISM; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIFUNGAL AGENTS; CATS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HAIR; MALE; NAPHTHALENES;

FELIDAE;

EID: 34547262654     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2007.00603.x     Document Type: Article

References (22)

1. Moriello K, Newbury S. Recommendations for the management and treatment of dermatophytosis in animal shelters. Veterinary Clinics of North America: Small Animal Practice 2006 36 : 89 114.
2. DeBoer D, Moriello K. Cutaneous fungal infections. In : Greene CE, ed. Infectious Diseases of the Dog and Cat, 3rd edn. St. Louis, MO : W. B. Saunders, 2006 550 69.
3. Miller WH, Kirk RW, Scott DW. Fungal skin diseases. In : Kirk's Small Animal Dermatology, 6th edn. Philadelphia, PA : W. B. Saunders, 2001 336 415.
4. Moriello KA. Treatment of dermatophytosis in dogs and cats: review of published studies. Veterinary Dermatology 2004 15 : 99 107.
5. Rottman JB, English RV, Breitschwerdt EB et al. Bone marrow hypoplasia in a cat treated with griseofulvin. Journal of the American Veterinary Medical Association 1991 198 : 429 31.
6. Helton KA, Nesbitt GH, Caciolo PL. Griseofulvin toxicity in cats: literature review and report of seven cases. Journal of the American Animal Hospital Association 1986 22 : 453 8.
7. Hofbauer B, Leitner I, Ryder NS. In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin. Medical Mycology 2002 40 : 179 83.
8. Balfour JA, Faulds D. Terbinafine-a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992 43 : 259 84.
9. Kotnik T, Kozuh Erzen N, Kuzner J et al. Terbinafine hydrochloride treatment of Microsporum canis experimentally induced ringworm in cats. Veterinary Microbiology 2001 83 : 161 8.
10. Mancianti F, Pedonese F, Millanta F et al. Efficacy of oral terbinafine in feline dermatophytosis due to Microsporum canis. Journal of Feline Medicine and Surgery 1999 1 : 37 41.
11. Chen C. The use of terbinafine for the treatment of dermatophytosis. Veterinary Dermatology 2000 11 (Suppl. 1 41.
12. Castanon-Olivares LR, Manzano-Gayosso P, Lopez-Martinez R. Effectiveness of terbinafine in the eradication of Microsporum canis from laboratory cats. Mycoses 2001 44 : 95 7.
13. Kotnik K. Drug efficacy of terbinafine hydrochloride (Lamisil®) during oral treatment of cats, experimentally infected with Microsporum canis. Journal of Veterinary Medicine B 2002 49 : 120 2.
14. Faergemann J, Zehender H, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clinical and Experimental Dermatology 1994 19 : 121 6.
15. Kužner J, Kozuh Erzen N, Drobnic-Kosorok M. Determination of terbinafine hydrochloride in cat hair by two chromatographic methods. Biomedical Chromatography 2001 15 : 497 502.
16. Majumdar TK, Bakhtiar R, Melamed D. Determination of terbinafine (Lamisil®) in human hair by microbore liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2000 14 : 1214 9.
17. Kovarik JM, Mueller EA, Zehender H. Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites. Antimicrobial Agents and Chemotherapy 1995 39 : 2738 41.
18. Faergemann J, Zehender H, Jones T. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. Acta Dermato-Venereologica 1990 71 : 322 6.
19. DeManuelle TC, Ihrke PJ, Brandt CM. Determination of skin concentrations of enrofloxacin in dogs with pyoderma. American Journal of Veterinary Research 1998 59 : 1599 604.
20. Kotnik T. Treatment with terbinafine of experimentally infected cats with M. canis: tolerability and side effects of the drug. Slovenian Veterinary Research 2000 37 : 67 76.
21. Gupta AK, Lynde CW, Lauzon GJ. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature. British Journal of Dermatology 1998 138 : 529 32.
22. Farhi D, Viguier M, Cosnes A. Terbinafine-induced subacute cutaneous lupus erythematosus. Dermatology 2006 212 : 59 65.